Clinical Trial Update: Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/Phase 2 trial evaluating a methylglyoxal-lowering cocktail for appetite reduction in obesity has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Methylglyoxal-lowering cocktail

Snippet

Sponsor: University of California, San Francisco | Conditions: Obesity, Aging | Phase 1, Phase 2 | Status: WITHDRAWN